ClinicalTrials.gg
RecruitingNCT07027930EMDR-IGTP-OTSUpdated Jun 19, 2025

A Feasibility Trial of Eye Movement Desensitization and Reprocessing Therapy- Integrative Treatment Group Protocol for Ongoing Traumatic Stress In Road Traffic Accident Survivors for Reduction of Post-traumatic Stress Symptoms

An interventional study of Eye movement desensitization and reprocessing therapy integrative group treatment protocol for Ongoing traumatic stress in Post Traumatic Stress Symptoms, Quality of Life (QOL) and Stress, sponsored by University of the Punjab. Recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2025-06-19.

Sponsored by University of the Punjab · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Primary completion was expected by Sep 2025, 1 year 1 month ago, but the record still lists the study as recruiting.
  • Started May 2025; still recruiting 1 year 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

Road traffic accidents (RTAs) are a significant public health concern globally, accounting for a substantial proportion of morbidity and mortality. This study evaluates the feasibility and acceptability of the Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol for Ongoing Traumatic Stress (EMDR-IGTP-OTS) in the reduction of posttraumatic stress symptoms, depression, and anxiety, while improving the quality of life in individuals who have experienced traffic accidents. Using a randomized control design, participants aged 18-45 will be assessed at three-time points: pre-treatment, post-treatment, and one-month follow-up. The study employs the DASS-21, UIES-R, and WHOQOL-BREF as evaluation measures. Findings aim to expand evidence on trauma-focused interventions and explore their applicability in culturally diverse, resource-constrained settings.

02

Conditions studied

  • Post Traumatic Stress Symptoms
  • Quality of Life (QOL)
  • Stress
03

In context

Lead sponsor

University of the Punjab is the lead sponsor of 20 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged between 18 and 45 years.
  • Experienced a traffic accident 3 months to 10 years prior
  • Willing to participate and able to understand the intervention components.

Exclusion criteria

Exclusion Criteria:

  • Participants will be excluded from the study if they meet any of the following criteria:

    • Diagnosed with conditions such as schizophrenia or bipolar disorder, which require specialized treatment beyond the scope of this study.
    • History of severe head injuries resulting in neurological or cognitive deficits.
    • Participants who have experienced a traffic accident less than 3 months ago, as immediate post-traumatic responses may not have stabilized
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
35 participants (estimated)

Study arms

  • Experimental
    EMDR-IGTP-OTS

    Eye movement desensitization and reprocessing therapy for ongoing traumatic stress

    Other: Eye movement desensitization and reprocessing therapy integrative group treatment protocol for Ongoing traumatic stress

  • No intervention
    Comparison Arm

    This would be used as a control arm

Interventions

  • OtherEye movement desensitization and reprocessing therapy integrative group treatment protocol for Ongoing traumatic stress

    EMDR-IGTP-OTS is a group intervention based on EMDR 8-phased protocols with the integration of the Butterfly hug technique.

06

What researchers measure

Primary outcomes

  1. The Urdu Impact of Event Scale-Revised

    It will measure trauma-specific symptoms such as intrusion, avoidance, and hyperarousal. This 22-item scale uses a 5-point Likert scale ranging from 0 (not at all) to 4 (extreme), comprehensively evaluating the psychological impact of traumatic incidents. Higher the scores, Higher will be severity of post traumatic symptoms.

    Time frame: From Enrollment to end of study after 4 weeks

07

Study locations

1 of 1 sites recruiting
  • Public Universities
    Lahore, Punjab 54000, Pakistan
    Recruiting
08

References and documents

Publications

  • Yasar AB, Konuk E, Kavakci O, Uygun E, Gundogmus I, Taygar AS, Uludag E. A Randomized-Controlled Trial of EMDR Flash Technique on Traumatic Symptoms, Depression, Anxiety, Stress, and Life of Quality With Individuals Who Have Experienced a Traffic Accident. Front Psychol. 2022 Mar 24;13:845481. doi: 10.3389/fpsyg.2022.845481. eCollection 2022. PubMed 35401305 ↗

Related links

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Individual Participant Data (IPD) will not be shared due to concerns regarding participant confidentiality, especially given the sensitive nature of trauma-related experiences addressed in the study. Although anonymization procedures are in place, the qualitative nature of the data and small sample size may still pose a risk of indirect identification. Therefore, to uphold ethical standards and protect participant privacy, we have decided not to share IPD publicly

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2025 (actual). Primary completion is estimated for Sep 2025, 4 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 30, 2025
First posted
Jun 19, 2025
StartActual
May 1, 2025
Primary completionEst.
Sep 25, 2025
CompletionEst.
Nov 1, 2025
Last update
Jun 19, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07027930
Lead sponsor
University of the Punjab
Responsible party
Khawer Javed (Principal Investigator, University of the Punjab) — Principal investigator
First posted
Jun 19, 2025
Start date
May 1, 2025
Primary completion
Sep 25, 2025 (estimated)
Completion
Nov 1, 2025 (estimated)
Last update
Jun 19, 2025

Study contacts

Khawer Javed, MS clinical Psychology
Contact
khwr348@gmail.com
+92 3415014715
Dr Nazia Bashir, Phd Clinical Psychology
Contact
nazia.ccpsy@pu.edu.pk
+92 321 4427751
Khawer Javed, MS clinical Psychology
principal investigator · Centre for clinical Psychology, University of the Punjab

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion